Navigation Links
New drug found effective against rare form of basal cell skin cancer
Date:6/6/2012

New York, NY (June 6, 2012) A clinical study has demonstrated that a new drug, a targeted molecular therapy called vismodegib (trade name Erivedge), can dramatically shrink basal cell skin cancers and prevent the formation of new ones, in patients with basal cell nevus syndrome (BCNS). This rare genetic condition causes dozens, and sometimes hundreds or thousands, of skin cancers on each patient's body. The primary treatment option is surgical removal. These study results are significant as they indicate the possibility of an alternative treatment with oral medication; although side effects remain a consideration.

The phase II clinical study, led by researchers at NewYork-Presbyterian Hospital/Columbia University Medical Center (NYPH/CUMC) and Children's Hospital of Oakland Research Institute (CHORI), was published today in the online edition of the New England Journal of Medicine.

"In its current formulation, vismodegib is appropriate only for BCNS patients with very large numbers of basal cell skin cancers. Still, this is a huge step forward, pointing to the day when we can offer every one of these patients an alternative to repeated surgery, which can be disfiguring and burdensome," said study co-leader David R. Bickers, MD, the Carl Truman Nelson Professor and chairman of dermatology at CUMC and director of dermatology at NewYork-Presbyterian Hospital/CUMC. The study was co-led by Ervin H. Epstein, Jr., MD, a senior scientist at CHORI.

The study is the first to evaluate vismodegib in patients with BCNS. Forty-two patients were randomized to receive either vismodegib (taken orally) or a placebo, for a maximum of 18 months. Overall, the study tracked more than 2,000 existing surgically eligible basal cell skin cancers (SEBs) and documented 694 new SEBs, on the 42 patients.

Patients taking vismodegib experienced an average of 2.3 new SEBs, compared with 29 for patients in the placebo group. Among patients taking t
'/>"/>

Contact: Elizabeth Streich
estreich@columbia.edu
212-305-3689
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. Highmark Foundation Awards $120,000 to the American Heart Association
4. Stuttering Foundation Hails New Research
5. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
6. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
7. Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett
8. Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts
9. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
10. Instaflex Announces Proceeds Agreement with Arthritis Foundation
11. AMERICAN IDOL to Benefit the UN Foundation Fund for Haiti Thursday, February 25, on FOX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, ... to put the brakes on motherhood. And for many young ... choice, new research suggests. Women in their early 20s ... during tough economic times. But, according to the new study, ... their 40s and beyond. The findings suggest that higher ...
(Date:9/30/2014)... the leading cause of cancer death in women, according ... medical professionals encourage women to get mammograms, even though ... of suspicious mammograms actually leads to a cancer diagnosis. ... women and their familiesnot to mention the time, discomfort ... , Recently, a different type of test, ultrasound ...
(Date:9/30/2014)... Dynamic health trends, changing consumer ... the Bread Production industry over the past five ... their consumption of a variety of industry goods ... the market for white loaf bread and other ... introducing more nutritious products to attract health-conscious consumers, ...
(Date:9/30/2014)... of Maryland-led research team has been awarded a ... of Health (NIH) to develop new imaging technologies ... understanding of how large networks of neurons in ... knowledge will help researchers identify the precise interactions ... like decision-making and speaking, and alterations in these ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
Breaking Medicine News(10 mins):Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 2Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 3Health News:'Virtual breast' could improve cancer detection 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... Though nursing is thought to reduce risk, more advanced tumors ... Women who breast-feed for six months or more face a ... cancer, but it,s not clear whether there,s a cause-and-effect relationship, ... these women are more likely to die of cancer than ...
... ... Experience in Style , ... March 26, 2010 -- Last week EarPeace provided hearing protection to thousands of music ... bands over the course of four days. The average decibel level at a concert is ...
... ... local and national organizations to help individuals in need. , ... Munster, IN (PRWEB) March 26, 2010 -- ... its efforts in giving back to the community and helping individuals in need of ...
... alcohol use tied to better lifestyle habits, study finds ... take worse care of themselves than other people, but ... who don,t imbibe, researchers have found. , "The main ... other behaviors -- such as relieving stress with alcohol ...
... beta-blockers can help reduce the spread of cancer in ... seventh European Breast Cancer Conference (EBCC7) in Barcelona today ... senior healthcare research scientist at Queen,s Medical Centre, Nottingham ... found that the group of patients treated with beta-blockers ...
... Spain: Two studies to be presented at the seventh ... and tomorrow (Saturday), shed light on the treatment options ... which predispose them to breast cancer. In the first, ... of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands, ...
Cached Medicine News:Health News:Long-Term Breast-Feeding Tied to More Aggressive Cancers 2Health News:EarPeace Protects Hearing for Thousands at South by Southwest 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 3Health News:Heavy Daily Drinking Linked to Worse Health 2Health News:Beta-blockers help reduce metastasis and improve survival in breast cancer patients 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 3Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 4
(Date:9/30/2014)... ALBANY, New York , September 30, 2014 /PRNewswire/ ... Market - Global Industry Analysis, Market Size, Share, Growth ... Research is expected to be worth USD 20.8 billion ... 29.5 billion in 2017, growing at a CAGR of ... are fundamental elements needed for various health purposes, especially ...
(Date:9/30/2014)...   Decision Resources Group finds that through ... kidney disease non-dialysis (CKD-ND) patients are not highly ... addition, one-year persistency is similar between Amgen,s Aranesp ... findings from the report entitled Treatment ... Agents in Late Stage Chronic Kidney Disease and ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
Breaking Medicine Technology:Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3
... InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical company ... has completed enrollment of a 360 patient Phase 2b ... PPAR gamma (SPPARM) for the treatment of Type 2 ... dose active comparator (45mg Actos(R)) and placebo controlled study ...
... the nation,s economic slowdown, America,s pharmaceutical research and ... year in the research and development of new ... roughly $2 billion from 2007, according to analyses ... (PhRMA) and Burrill & Company. PhRMA-member companies ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 3R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 4
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... The ITREL 3 is a battery powered ... the U.S., ,Enterra™ Therapy is indicated ... vomiting associated with gastroparesis when conventional drug ... symptons for diabetic or idiopathic patients., ...
... rapid qualitative test for detection of cardiac ... samples. It can be used as an ... and can be useful to assess if ... angina (e.g. gastric pain, strained chest muscles, ...
Medicine Products: